Brewin Dolphin Wealth Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $4K | Sell |
300
-448
| -60% | -$5.97K | ﹤0.01% | 313 |
|
|
2022
Q1 | $11K | Buy |
748
+448
| +149% | +$6.59K | ﹤0.01% | 285 |
|
|
2021
Q4 | $4K | Hold |
300
| – | – | ﹤0.01% | 308 |
|
|
2021
Q3 | $4.91K | Hold |
300
| – | – | ﹤0.01% | 312 |
|
|
2021
Q2 | $5.05K | Hold |
300
| – | – | ﹤0.01% | 313 |
|
|
2021
Q1 | $5.48K | Hold |
300
| – | – | ﹤0.01% | 301 |
|
|
2020
Q4 | $5.46K | Hold |
300
| – | – | ﹤0.01% | 261 |
|
|
2020
Q3 | $5.35K | Hold |
300
| – | – | ﹤0.01% | 256 |
|
|
2020
Q2 | $5.38K | Hold |
300
| – | – | ﹤0.01% | 264 |
|
|
2020
Q1 | $4.55K | Buy |
+300
| New | +$4.55K | ﹤0.01% | 185 |
|